Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for more than 60% of pharmaceutical sales, and professional diagnostics for more than half of diagnostic-related sales.
| Website: | www.roche.com |
| Email: | investor.relations@roche.com |
| Main Phone: | +41 616881111 |
| Address: | F. Hoffmann-La Roche AG |
| Address 2: | Grenzacherstrasse 124 |
| City / Town: | Basel |
| Country: | CHE |
| Postal Code: | CH-4070 |
| Exchange: | OTCQX |
| Employees: | 80080 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 249.03 | Change $ -5.37 | Change % -2.11 | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open 251.45 | High 251.95 | Low 249.03 | Prev Close 254.40 |
| Last Trade | Volume 315 | 52 Wk Hi 260.04 | 52 Wk Low 209.55 |
| Market Cap 212.7 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 854,173,567.00 | EPS (TTM) 12.25 | PE Ratio 20.20 | Exchange OTCQX |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
